We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

66 hedge funds and large institutions have $64.9M invested in Niagen Bioscience in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

56% more capital invested

Capital invested by funds: $41.6M → $64.9M (+$23.3M)

53% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 17

8% more funds holding

Funds holding: 61 → 66 (+5)

1.65% more ownership

Funds ownership: 21.36% → 23.01% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $80K

Holders
66
Holders Change
+5
Holders Change %
+8.2%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
26
Reduced
17
Closed
5
Calls
–
Puts
$80K
Net Calls
-$80K
Net Calls Change
-$170K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.03M
2
BlackRock
BlackRock
New York
+$1.61M
3
Renaissance Technologies
Renaissance Technologies
New York
+$941K
4
MAM
Martingale Asset Management
Massachusetts
+$901K
5
Two Sigma Investments
Two Sigma Investments
New York
+$648K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tieton Capital Management
Washington
-$2.01M
2
SIG
Sargent Investment Group
Maryland
-$367K
3
Citadel Advisors
Citadel Advisors
Florida
-$196K
4
MMA
Miracle Mile Advisors
California
-$112K
5
Group One Trading
Group One Trading
Illinois
-$90K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$13M +$1.61M +359,728 +15%
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.4M +$234K +52,290 +2%
IC
3
Iconiq Capital
California
$7.84M – – –
TCM
4
Tieton Capital Management
Washington
$4.67M -$2.01M -448,762 -31%
UIC
5
Uniplan Investment Counsel
Wisconsin
$3.52M -$78.8K -17,592 -2%
State Street
6
State Street
Massachusetts
$3.35M +$146K +32,560 +5%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$2.81M +$113K +25,350 +4%
Northern Trust
8
Northern Trust
Illinois
$2.32M +$56.2K +12,542 +3%
Morgan Stanley
9
Morgan Stanley
New York
$2.14M +$2.03M +453,136 +3,480%
SA
10
Sycale Advisors
New York
$1.65M +$200K +44,721 +14%
JMPWA
11
JP Morgan Private Wealth Advisors
California
$1.28M – – –
Renaissance Technologies
12
Renaissance Technologies
New York
$965K +$941K +210,200 New
UBS Group
13
UBS Group
Switzerland
$926K -$83K -18,538 -8%
MAM
14
Martingale Asset Management
Massachusetts
$924K +$901K +201,225 New
Two Sigma Investments
15
Two Sigma Investments
New York
$665K +$648K +144,818 New
N
16
Nuveen
North Carolina
$637K +$134K +29,849 +27%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$602K -$13.5K -3,014 -2%
Bessemer Group
18
Bessemer Group
New Jersey
$532K +$518K +115,800 New
Wells Fargo
19
Wells Fargo
California
$476K +$120K +26,838 +35%
Charles Schwab
20
Charles Schwab
California
$462K +$12K +2,673 +3%
Millennium Management
21
Millennium Management
New York
$455K +$443K +99,049 New
RJFSA
22
Raymond James Financial Services Advisors
Florida
$398K -$8.62K -1,925 -2%
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$379K +$243K +54,300 +193%
MYIA
24
Mount Yale Investment Advisors
Colorado
$315K – – –
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$291K – – –
1
2 3

NAGE Hedge Fund Activity: Q2 2020 in Review

66 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2020, worth a combined $64.9M — up 56% from $41.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NAGE positions and 5 closed out — a net gain of 6 holders — while 26 added to existing stakes and 17 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.03M. The largest seller was Tieton Capital Management, cutting an estimated $2.01M.

  • 66 institutional investors held Niagen Bioscience (NAGE) as of Q2 2020, up from 61 in Q1 2020.
  • Funds reported $64.9M of Niagen Bioscience stock for Q2 2020, up 56% quarter-over-quarter.
  • 11 funds opened new Niagen Bioscience positions in Q2 2020 and 5 closed out, a net change of +6 holders.
  • The largest Niagen Bioscience buyer in Q2 2020 was Morgan Stanley, an estimated $2.03M added.
  • The largest Niagen Bioscience seller in Q2 2020 was Tieton Capital Management, an estimated $2.01M sold.

Based on aggregated 13F filings for Q2 2020.